April 8, 2020
India to Face US Wrath Said Trump if Not Overturning Banned Covid-19 Drug Decision
India may face wrath against the US if Indian Prime Minister Narendra Modi will not overturn the decision of banning a potential drug for COVID-19, which they experimented to treat the pandemic virus.
This drug is what they call hydroxychloroquine (HCQ) and it is a kind of anti-malaria medication.
From the latest information online through RT.com, United States President Donald Trump said that if Indian Prime Minister (PM) Modi will not decide to overturn the decision to export the banned COVID-19 drug, India might be facing wrath against the Americans.
New Delhi has experimented a certain drug known as hydroxychloroquine, which can possible treat the virus caused by the Novel Coronavirus 2019 or COVID-19. The White House leader made a statement that the PM must reverse the decision to ban such drug from entering America and in other nations.
This particular issue originated when New Delhi made a decision to implement a “blanket ban” on exporting the anti-malaria drug. This is still under clinical test because they still want to prove its effectiveness if it can treat patients with COVID-19.
Trump on the other had said the PM might face the consequences for not allowing the drug and insisted that he does not know anything about the concluded final decision of the PM.
“I don’t like that decision. I didn’t hear if that was his decision. I know he stopped it for other countries,” said Trump said as published online (referring to the Indian PM). “I would be surprised if he would, because India does very well with the United States, for many years they’ve been taking advantage of the United States on trade,” he added.
The United States had been receiving nearly half of the produced drug of the suppliers from India, as detailed by Bloomberg News. This is one reason why the US leader had been repeatedly touting the anti-malaria medicine as a possible treatment to fight the pandemic virus.
Although there is still no concrete evidence that can prove the potentiality of the drug against COVID-19, there had been ongoing clinical tests in Michigan and in New York. Furthermore, the tests showed initial findings that the HCQ could possibly be helpful, as explained by Jerome Adams.
Adams is the Surgeon General of the United States.
Because of learning about the statement of Trump a couple of days ago, India had already made a decision to lift the ban and allowed the export of almost 24 pharmaceutical drugs and ingredients. All of these contain the intriguing anti-malaria drug.
This latest development would certainly make the US President happy because they can now proceed to the tests to fight such deadly virus at once.
“Like any responsible government, our first obligation is to ensure that there are adequate stocks of medicines for the requirement of our own people. In order to ensure this, some temporary steps were taken to restrict exports of a number of pharmaceutical products,” said in a statement by Anurag Srivastava on Tuesday as published through knoowherenews.com.
He also said that, “It has been decided that India would license paracetamol and HCQ in appropriate quantities to all our neighboring countries who are dependent on our capabilities,” adding that the “restrictions have been largely lifted” after confirming the availability of these medicines “for all possible contingencies currently envisaged.”
Anurag Srivastava is the current representative of the Indian foreign ministry.